## Company Overview
OpenEvidence is the leading medical information platform, launched from the Mayo Clinic Platform Accelerate program. The company aims to organize and expand the world's collective medical knowledge by aggregating, synthesizing, and visualizing clinically relevant evidence in understandable formats. OpenEvidence has signed content agreements with JAMA and The New England Journal of Medicine.

## Business Model and GTM
OpenEvidence is free and unlimited for healthcare professionals (HCPs) in the U.S. The company focuses on providing access to multimedia and clinical findings from reputable medical journals, which helps healthcare professionals make evidence-based decisions and improve patient outcomes.

## Funding & Investor Profile
OpenEvidence has received investments from notable firms including Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Blackstone, and Mayo Clinic, among others.

## Growth Momentum
Not disclosed.

## Visibility & Market Sentiment
The company states that the amount of medical research published annually is doubling every five years, creating an extreme challenge in medicine. OpenEvidence addresses this challenge by providing a platform that helps healthcare professionals monitor and understand the latest research literature and clinical evidence relevant to their work.

## Risks and Challenges
Not disclosed.

## Outlook
Not disclosed.

## Disclosure Gaps
- Growth momentum details are not disclosed.
- Specific risks and challenges faced by the company are not disclosed.
- Outlook for the company is not disclosed.
